Audiological characteristics in mucopolysaccharidosis: a systematic literature review
Características audiológicas na mucopolissacaridose: revisão sistemática da literatura
Flávia Teixeira Chimelo; Liliane Aparecida Fagundes Silva; Chong Ae Kim; Carla Gentile Matas
Abstract
Purpose: to describe the audiological characteristics of patients with mucopolysaccharidosis.
Methods: after formulating the research question, three databases were considered for the search (Science Direct, Virtual Health Library and Web of Science); the following descriptors were used: mucopolysaccharidoses, hearing loss, and audiology. Articles were included that were original and complete, presenting audiological evaluation data in patients with mucopolysaccharidosis. Each study was classified according to the degree of recommendation and the level of scientific evidence, based on the criteria established by the Oxford Center for Evidence-based Medicine, and the results obtained from the evaluations were analyzed.
Results: of the 499 articles found, eight met the inclusion criteria. Pure tone audiometry and tympanometry were performed in all studies. The incidence of hearing loss in patients with MPS ranged from 54% to 100% of the cases, with conductive hearing loss corresponding to 30% and 58.33%, mixed hearing loss corresponding to 28.5% and 66.66% and sensorineural hearing loss corresponding to less than 14%. None of the studies described the responses of otoacoustic emissions and auditory evoked potentials.
Conclusion: the prevalence of hearing loss among individuals with MPS is higher than 54% of the cases, of which conductive and mixed are predominant.
Keywords
Resumo
Objetivo: descrever as características audiológicas de pacientes com Mucopolissacaridose.
Métodos: após formular a pergunta de pesquisa, foram consideradas três bases de dados (Science Direct, Biblioteca Virtual em Saúde e Web of Science), sendo utilizados os seguintes descritores: mucopolissacaridoses, perda auditiva, audiologia. Foram incluídos artigos originais e completos, que apresentavam dados de avaliação audiológica em pacientes com mucopolissacaridose. Cada estudo foi classificado de acordo com o grau de recomendação e o nível de evidência científica, baseado nos critérios estabelecidos pela Oxford Centre for Evidence-based Medicine, e foram analisados os resultados obtidos nas avaliações.
Resultados: dentre os 499 artigos encontrados, oito contemplaram os critérios de inclusão. A audiometria tonal e a timpanometria foram realizadas em todos os estudos. A incidência de perda auditiva em pacientes com MPS variou entre 54% a 100% dos casos, sendo que as perdas auditivas condutivas corresponderam à 30% e 58,33%, as perdas auditivas mistas corresponderam à 28,5% e 66,66% e as perdas auditivas neurossensoriais corresponderam à menos de 14%. Nenhum dos estudos descreveu as respostas das emissões otoacústicas e dos potenciais evocados auditivos.
Conclusão: a prevalência de perda auditiva entre indivíduos com MPS é superior à 54% dos casos, sendo esta predominantemente condutiva e mista.
Palavras-chave
Referencias
1. Yeung AH, Cowan MJ, Horn B, Rosbe KW. Airway management in children with mucopolysaccharidoses. Arch Otolaryngol Head Neck Surg. 2009;135(1):73-9.
2. Neufeld EF, Muenzer J. The mucopolysacharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (orgs). The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGray-Hill; 2001.p.3421-52.
3. Simmons MA, Bruce IA, Penney S, Wraith E, Rothera MP. Otorhinolaryngological manifestations of the mucopolysaccharidoses. Int. J. Pediatri. Otorhinolaryngol. 2005;69(5):589-95.
4. Bicalho CG, Rezende MM, Nogueira AMCM, Paulon RMC, Acosta AX. A importância da avaliação otorrinolaringológica de pacientes com mucopolissacaridose. Arquivos Int. Otorrinolaringol. 2011;15(3):290-4.
5. Schleier E, Streubel HG. Aspectos foniátricos de crianças com Mucopolissacaridose. Folia. Phoniatr. 1976;28:65-72.
6. Santos CMC, Pimenta CAM, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15(3):508-11.
7. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med. 2009:18;151(4):264-9.
8. Oxford Centre for Evidence-based Medicine – Levels of Evidence. Março de 2009. Disponível em: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Acesso em: 25 de Junho de 2018.
9. Papsin BC, Vellodi A, Bailey CM, Ratcliffe PC, Leighton SE. Otologic and laryngologic manifestations of mucopolysaccharidoses after bone marrow transplantation. Otolaryngol Head Neck Surg. 1998;118(1):30-6.
10. Gomes AB, Pereira RG, Vassoler TMF, Alcantara LJL, Zimmermann E, Santos MLSF. Avaliação audiológica de pacientes com mucopolissacaridose em um hospital pediátrico. Arquivos Int. Otorrinolaringol. 2011;15(2):203-7.
11. Vargas-Gamarra MF, de Paula-Vernetta C, Vitoria Miñana I, Ibañez-Alcañiz I, Cavallé-Garrido L, Alamar-Velazquez A. Audiological findings in children with mucopolysaccharidoses type i-iv. Acta Otorrinolaringologica. 2017;68(5):262-8.
12. Costa V, O'Grady G, Jackson L, Kaylie D, Raynor E. Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis. Arch Otolaryngol Head Neck Surg. 2012;138(11):1071-6.
13. Mesolella M, Cimmino M, Cantone E, Marino A, Cozzolino M, Della Casa R et al. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience. Acta Otorhinolaryngologica Italica. 2013;33(4):267-2.
14. Lin HY, Shih SC, Chuang CK, Lee KS, Chen MR, Lin HC et al. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses. Mol Genet Metab. 2014;111(4):533-8.
15. Gökdoğan Ç, Altinyay Ş, Gökdoğan O, Tutar H, Gündüz B, Okur İ et al. Audiologic evaluations of children with mucopolysaccharidosis. Braz J Otorhinolaryngol. 2016;82(3):281-4.
16. Dualibi APFF, Martins AM, Moreira GA, Azevedo MF, Fujita RR, Pignatari SSN. The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis. Braz. j. Otorhinolaryngol. 2016;82(5):522-8.
17. Mustacchi Z, Peres S. Genética bioquímica - Erros inatos do matabolismo. In: Mustacchi Z, Peres S (orgs). Genética baseada em evidências: Síndromes e heranças. São Paulo: CID editora; 2000. p. 429-77.
18. Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Nat Acad Sci USA. 1990;87(5):1913-6.
19. Viana GM, Cavaleiro R, Alves E, Souza IC, Feio R, Leistner-Segal S et al. Mucopolissacaridoses no norte do Brasil: rastreamento de mutações direcionadas e excreção de glicosaminoglicanos urinários em pacientes submetidos à terapia de reposição enzimática. Genet Mol Biol. 2011;34(3):4105.
Submitted date:
30/10/2018
Accepted date:
12/08/2019
Facebook
Twitter
LinkedIn
Mendeley
Email